Abstract
Bacterial and synthetic DNAs containing CpG dinucleotides in specific sequence contexts activate the vertebrate immune system through Toll-like receptor 9 (TLR9). In the present study, we used a synthetic nucleoside with a bicyclic heterobase [1-(2'-deoxy-beta-d-ribofuranosyl)-2-oxo-7-deaza-8-methyl-purine; R] to replace the C in CpG, resulting in an RpG dinucleotide. The RpG dinucleotide was incorporated in mouse- and human-specific motifs in oligodeoxynucleotides (oligos) and 3'-3-linked oligos, referred to as immunomers. Oligos containing the RpG motif induced cytokine secretion in mouse spleen-cell cultures. Immunomers containing RpG dinucleotides showed activity in transfected-HEK293 cells stably expressing mouse TLR9, suggesting direct involvement of TLR9 in the recognition of RpG motif. In J774 macrophages, RpG motifs activated NF-kappa B and mitogen-activated protein kinase pathways. Immunomers containing the RpG dinucleotide induced high levels of IL-12 and IFN-gamma, but lower IL-6 in time- and concentration-dependent fashion in mouse spleen-cell cultures costimulated with IL-2. Importantly, immunomers containing GTRGTT and GARGTT motifs were recognized to a similar extent by both mouse and human immune systems. Additionally, both mouse- and human-specific RpG immunomers potently stimulated proliferation of peripheral blood mononuclear cells obtained from diverse vertebrate species, including monkey, pig, horse, sheep, goat, rat, and chicken. An immunomer containing GTRGTT motif prevented conalbumin-induced and ragweed allergen-induced allergic inflammation in mice. We show that a synthetic bicyclic nucleotide is recognized in the C position of a CpG dinucleotide by immune cells from diverse vertebrate species without bias for flanking sequences, suggesting a divergent nucleotide motif recognition pattern of TLR9.
MeSH Terms
Adjuvants, Immunologic/chemical synthesis,chemistry,pharmacology
Allergens
Animals
Base Sequence
Cell Line
Cells, Cultured
Cytokines/biosynthesis
DNA-Binding Proteins/genetics,immunology
Drug Design
Female
Humans
Kinetics
MAP Kinase Signaling System/drug effects
Mice
Mice, Inbred BALB C
Oligodeoxyribonucleotides/chemical synthesis,chemistry,pharmacology
Organ Size/drug effects
Receptors, Cell Surface/genetics,immunology
Species Specificity
Spleen/anatomy & histology,drug effects,immunology
Th1 Cells/drug effects,immunology
Toll-Like Receptor 9
Transfection
Chemicals
Adjuvants, Immunologic
Allergens
CPG-oligonucleotide
Cytokines
DNA-Binding Proteins
Oligodeoxyribonucleotides
Receptors, Cell Surface
TLR9 protein, human
Tlr9 protein, mouse
Toll-Like Receptor 9
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Kandimalla Ekambar R
Hybridon, Inc., 345 Vassar Street, Cambridge, MA 02139, USA.
Bhagat Lakshmi
Zhu Fu-Gang
Yu Dong
Cong Yan-Ping
Wang Daqing
Tang Jimmy X
Tang Jin-Yan
Knetter Cathrine F
Lien Egil
Agrawal Sudhir
References (33)
33 references, click to expand
-
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
J Immunol. 2000 Feb 1;164(3):1617-24
PMID: 10640783
-
Effect of chemical modifications of cytosine and guanine in a CpG-motif of oligonucleotides: structure-immunostimulatory activity relationships.
Bioorg Med Chem. 2001 Mar;9(3):807-13
PMID: 11310616
-
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9237-42
PMID: 11470918
-
Modulation of immunostimulatory activity of CpG oligonucleotides by site-specific deletion of nucleobases.
Bioorg Med Chem Lett. 2001 Sep 3;11(17):2263-7
PMID: 11527711
-
Immunostimulatory activity of CpG oligonucleotides containing non-ionic methylphosphonate linkages.
Bioorg Med Chem. 2001 Nov;9(11):2803-8
PMID: 11597460
-
Immunopharmacology of CpG DNA.
Biol Chem. 2002 Oct;383(10):1491-500
PMID: 12452427
-
Requirement of nucleobase proximal to CpG dinucleotide for immunostimulatory activity of synthetic CpG DNA.
Bioorg Med Chem. 2003 Feb 6;11(3):459-64
PMID: 12517441
-
CpG penta- and hexadeoxyribonucleotides as potent immunomodulatory agents.
Biochem Biophys Res Commun. 2003 Jan 24;300(4):853-61
PMID: 12559951
-
Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles.
Nucleic Acids Res. 2003 May 1;31(9):2393-400
PMID: 12711684
-
Immunostimulatory DNA for asthma: better than eating dirt.
Am J Respir Cell Mol Biol. 2003 Jun;28(6):645-7
PMID: 12760961
-
Toll-like receptor 9: modulation of recognition and cytokine induction by novel synthetic CpG DNAs.
Biochem Soc Trans. 2003 Jun;31(Pt 3):654-8
PMID: 12773176
-
Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1.
Biochem Pharmacol. 1993 May 25;45(10):2037-43
PMID: 8512586
-
CpG motifs in bacterial DNA trigger direct B-cell activation.
Nature. 1995 Apr 6;374(6522):546-9
PMID: 7700380
-
Effect of different chemically modified oligodeoxynucleotides on immune stimulation.
Biochem Pharmacol. 1996 Jan 26;51(2):173-82
PMID: 8615886
-
G/C-modified oligodeoxynucleotides with selective complementarity: synthesis and hybridization properties.
Nucleic Acids Res. 1996 Jul 1;24(13):2470-5
PMID: 8692683
-
Macrophages ingest and are activated by bacterial DNA.
J Immunol. 1996 Sep 1;157(5):2116-22
PMID: 8757335
-
Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice.
Antisense Nucleic Acid Drug Dev. 1997 Oct;7(5):495-502
PMID: 9361908
-
Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA.
J Immunol. 1998 Nov 1;161(9):4493-7
PMID: 9794373
-
CpG motifs in bacterial DNA and their immune effects.
Annu Rev Immunol. 2002;20:709-60
PMID: 11861616
-
Medicinal chemistry and therapeutic potential of CpG DNA.
Trends Mol Med. 2002 Mar;8(3):114-21
PMID: 11879771
-
Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development.
Jpn J Infect Dis. 2002 Apr;55(2):37-44
PMID: 12082305
-
Antisense and/or immunostimulatory oligonucleotide therapeutics.
Curr Cancer Drug Targets. 2001 Nov;1(3):197-209
PMID: 12188879
-
Potent CpG oligonucleotides containing phosphodiester linkages: in vitro and in vivo immunostimulatory properties.
Biochem Biophys Res Commun. 2002 Sep 13;297(1):83-90
PMID: 12220512
-
Conjugation of ligands at the 5'-end of CpG DNA affects immunostimulatory activity.
Bioconjug Chem. 2002 Sep-Oct;13(5):966-74
PMID: 12236778
-
Design, synthesis, and immunostimulatory properties of CpG DNAs containing alkyl-linker substitutions: role of nucleosides in the flanking sequences.
J Med Chem. 2002 Sep 26;45(20):4540-8
PMID: 12238933
-
'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.
Nucleic Acids Res. 2002 Oct 15;30(20):4460-9
PMID: 12384593
-
In vivo role of p38 mitogen-activated protein kinase in mediating the anti-inflammatory effects of CpG oligodeoxynucleotide in murine asthma.
J Immunol. 2002 Nov 15;169(10):5955-61
PMID: 12421981
-
Introduction to immunostimulatory DNA sequences.
Springer Semin Immunopathol. 2000;22(1-2):1-9
PMID: 10944795
-
Mechanisms of immune stimulation by bacterial DNA.
Springer Semin Immunopathol. 2000;22(1-2):21-33
PMID: 10944797
-
CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma.
J Immunol. 2000 Nov 15;165(10):5906-12
PMID: 11067952
-
A Toll-like receptor recognizes bacterial DNA.
Nature. 2000 Dec 7;408(6813):740-5
PMID: 11130078
-
Accessible 5'-end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity.
Bioorg Med Chem Lett. 2000 Dec 4;10(23):2585-8
PMID: 11128629
-
Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.
Exp Hematol. 2000 May;28(5):558-68
PMID: 10812246